Celldex Therapeutics Eulerpool News

Celldex Therapeutics Eulerpool News

Celldex Therapeutics Stock News

Celldex Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Celldex Therapeutics news here.

• September 30 ·

  Thefly.com
  Disney upgraded, JPMorgan downgraded: Wall Street's top analyst calls
• September 30 ·

  Thefly.com
  Celldex initiated with neutral view at Goldman Sachs, here's why
• September 30 ·

  TipRanks
  Hold Rating on Celldex Therapeutics Amid Drug Development Prospects and Competitive Challenges
• September 26 ·

  Yahoo
  CLDX Stock Down Despite Upbeat Long-Term Data From Urticaria Study
• September 26 ·

  Thefly.com
  Wolfe Research cuts Celldex to Peer Perform, sees negative risk-reward skew
• September 25 ·

  Yahoo
  Celldex Therapeutics Presents Landmark 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV 2024
• September 25 ·

  Seeking Alpha
  Celldex stock tumbles 24% amid Phase 2 data release for barzolvolimab
• September 25 ·

  Seeking Alpha
  Celldex stock tumbles 18% amid Phase 2 data release for barzolvolimab (update)
• September 18 ·

  TipRanks
  Celldex (CLDX) Receives a Buy from Cantor Fitzgerald
• September 16 ·

  Yahoo
  Celldex Announces Upcoming Late Breaking Oral Presentation of 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV Congress 2024